Trial Profile
Effect of ticagrelor in patients with acute coronary syndrome who were showing low response to prasugrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 22 Apr 2015 New trial record